Novo Nordisk

News

The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.

News

FulcrumSec has reportedly offered data from a Novo Nordisk breach for sale after a $25m ransom was rejected, but has a second breach also occurred?

News

Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, confirming a breach exposed some patient data.

News

Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.

News

Lilly reveals more details of its retatrutide obesity and diabetes studies, plus trial updates from Zealand/Roche, Pfizer, Novo Nordisk, and Sciwind.

News

France's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.